Related Experiment Video
Updated: Dec 16, 2025
09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.2K
Seizures in Children.
Anthony Fine1, Elaine C Wirrell1
1Division of Epilepsy and Division of Child and Adolescent Neurology, Department of Neurology, Mayo Clinic, Rochester, MN.
Pediatrics in Review
|July 3, 2020
Summary
Pediatric epilepsy, common in infants, requires accurate diagnosis due to seizure mimics. Genetic testing and neuroimaging aid in identifying causes, while comorbidities like intellectual disability are frequent.
Area of Science:
- Pediatric Neurology
- Clinical Neuroscience
- Childhood Epilepsy Syndromes
Background:
- Epilepsy is a prevalent neurologic disorder in children, with peak incidence in the first year of life.
- Accurate diagnosis is often challenging due to the presence of seizure mimics.
- Early identification and management are crucial for optimal outcomes.
Purpose of the Study:
- To highlight the diagnostic challenges in pediatric epilepsy.
- To emphasize the importance of electroencephalography, neuroimaging, and genetic testing.
- To underscore the high prevalence of comorbidities in children with epilepsy.
Main Methods:
- Review of diagnostic modalities including electroencephalography and neuroimaging.
- Discussion of the utility of genetic testing in early-life epilepsies.
- Analysis of the incidence of drug-resistant seizures and associated comorbidities.
Main Results:
- Diagnostic accuracy in pediatric epilepsy is complicated by seizure mimics.
- Electroencephalography, neuroimaging, and genetic testing are vital for etiological and syndromic determination.
- Up to 25% of children develop drug-resistant epilepsy.
- Comorbidities such as intellectual disability (25%), learning disability, and ADHD are common.
Conclusions:
- Comprehensive diagnostic approaches are essential for pediatric epilepsy.
- Genetic testing offers high yield, especially in early-onset cases.
- Recognizing and managing comorbidities is integral to the holistic care of children with epilepsy.
More Related Videos
Related Concept Videos
01:13Seizures: Classification
1.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
01:24Epilepsy and Seizures: Overview
1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K
01:17Antiepileptic Drugs: Calcium Channel Blockers
986
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
986
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
705
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
705
01:20Antiepileptic Drugs: Potassium Channel Activators
503
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
503